India's Drug Regulator Issues Warning Against Injectable Cosmetics
No cosmetic job with jabs, warns drug regulator CDSCO
Image: The Economic Times
India's Central Drugs Standard Control Organisation (CDSCO) has issued a warning against the use of injectable cosmetics, citing concerns over the rising trend of GLP-1 drugs for aesthetic purposes. The advisory emphasizes that cosmetics should only be applied topically and not injected, as they fall under the Drugs and Cosmetics Act, 1940.
- 01The CDSCO's advisory prohibits the use of cosmetics for injection, stating they are only meant for topical application.
- 02The notice, issued on May 18, 2023, aims to address the misuse of products in aesthetic clinics amidst the rising popularity of GLP-1 drugs.
- 03Experts note that the warning may also encompass other injectable treatments like Botox, which is classified as a prescription-only pharmaceutical drug.
- 04Although no formal cases of misuse have been reported, authorities suspect that such practices may be occurring clandestinely in aesthetic clinics.
- 05The advisory is a response to the increasing normalization of injectable aesthetic treatments, which blur the lines between cosmetics and medical procedures.
Advertisement
In-Article Ad
The Central Drugs Standard Control Organisation (CDSCO) of India has issued a crucial advisory warning against the use of injectable cosmetics, particularly in light of the growing popularity of GLP-1 receptor agonists for aesthetic enhancement. This notice, released on May 18, 2023, emphasizes that cosmetics should only be applied topically and not injected, as per the provisions of the Drugs and Cosmetics Act, 1940, and the Cosmetics Rules, 2020. The rise of injectable treatments, including skin-brightening glutathione drips and collagen injections, has led to concerns about the misuse of products in aesthetic clinics. While no formal cases of misuse have been reported, there are fears that such practices may be occurring in secret. The advisory also highlights that products like Botox, which are legally classified as prescription-only drugs, should not be confused with cosmetic injections. As the trend of injectable treatments continues to grow, the CDSCO aims to curb potential misuse and protect consumer safety.
Advertisement
In-Article Ad
This advisory is expected to impact aesthetic clinics across India, potentially leading to a reduction in the availability of injectable cosmetic treatments.
Advertisement
In-Article Ad
Reader Poll
Do you think injectable cosmetics should be regulated more strictly?
Connecting to poll...
More about Central Drugs Standard Control Organisation
Read the original article
Visit the source for the complete story.